Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Vaginal atrophy, also known as urogenital atrophy or atrophic vaginitis, is the inflammation of the vagina. It is the result of the vaginal tissues getting shrunken and thinned out. The most common cause of vaginal atrophy is the lack of estrogen, the female reproductive hormone. Vaginal atrophy can be caused during perimenopause and can get aggravated in the postmenopausal phase.
This report offers an overview of the market trends, drivers, and barriers with respect to the China Postmenopausal Vaginal Atrophy Treatment market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Postmenopausal Vaginal Atrophy Treatment market. Detailed analysis of key players, along with key growth strategies adopted by Postmenopausal Vaginal Atrophy Treatment industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Teva Pharmaceutical
Shionogi
Novo Nordisk
Allergan
Pfizer
By Type:
Creams
Tablets
Patches
Rings
By End-User:
Topical Estrogen
Systemic Estrogen
Non-hormonal
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Postmenopausal Vaginal Atrophy Treatment Market
-
1.3 Market Segment by Type
-
1.3.1 China Postmenopausal Vaginal Atrophy Treatment Market Size and Growth Rate of Creams from 2016 to 2027
-
1.3.2 China Postmenopausal Vaginal Atrophy Treatment Market Size and Growth Rate of Tablets from 2016 to 2027
-
1.3.3 China Postmenopausal Vaginal Atrophy Treatment Market Size and Growth Rate of Patches from 2016 to 2027
-
1.3.4 China Postmenopausal Vaginal Atrophy Treatment Market Size and Growth Rate of Rings from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Postmenopausal Vaginal Atrophy Treatment Market Size and Growth Rate of Topical Estrogen from 2016 to 2027
-
1.4.2 China Postmenopausal Vaginal Atrophy Treatment Market Size and Growth Rate of Systemic Estrogen from 2016 to 2027
-
1.4.3 China Postmenopausal Vaginal Atrophy Treatment Market Size and Growth Rate of Non-hormonal from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Postmenopausal Vaginal Atrophy Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Postmenopausal Vaginal Atrophy Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Postmenopausal Vaginal Atrophy Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Postmenopausal Vaginal Atrophy Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Postmenopausal Vaginal Atrophy Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Postmenopausal Vaginal Atrophy Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Postmenopausal Vaginal Atrophy Treatment Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Postmenopausal Vaginal Atrophy Treatment Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Postmenopausal Vaginal Atrophy Treatment by Major Types
-
3.4.1 Market Size and Growth Rate of Creams
-
3.4.2 Market Size and Growth Rate of Tablets
-
3.4.3 Market Size and Growth Rate of Patches
-
3.4.4 Market Size and Growth Rate of Rings
4 Segmentation of Postmenopausal Vaginal Atrophy Treatment Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Postmenopausal Vaginal Atrophy Treatment by Major End-Users
-
4.4.1 Market Size and Growth Rate of Postmenopausal Vaginal Atrophy Treatment in Topical Estrogen
-
4.4.2 Market Size and Growth Rate of Postmenopausal Vaginal Atrophy Treatment in Systemic Estrogen
-
4.4.3 Market Size and Growth Rate of Postmenopausal Vaginal Atrophy Treatment in Non-hormonal
5 Market Analysis by Regions
-
5.1 China Postmenopausal Vaginal Atrophy Treatment Production Analysis by Regions
-
5.2 China Postmenopausal Vaginal Atrophy Treatment Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Postmenopausal Vaginal Atrophy Treatment Landscape Analysis
-
6.1 North China Postmenopausal Vaginal Atrophy Treatment Landscape Analysis by Major Types
-
6.2 North China Postmenopausal Vaginal Atrophy Treatment Landscape Analysis by Major End-Users
7 Central China Postmenopausal Vaginal Atrophy Treatment Landscape Analysis
-
7.1 Central China Postmenopausal Vaginal Atrophy Treatment Landscape Analysis by Major Types
-
7.2 Central China Postmenopausal Vaginal Atrophy Treatment Landscape Analysis by Major End-Users
8 South China Postmenopausal Vaginal Atrophy Treatment Landscape Analysis
-
8.1 South China Postmenopausal Vaginal Atrophy Treatment Landscape Analysis by Major Types
-
8.2 South China Postmenopausal Vaginal Atrophy Treatment Landscape Analysis by Major End-Users
9 East China Postmenopausal Vaginal Atrophy Treatment Landscape Analysis
-
9.1 East China Postmenopausal Vaginal Atrophy Treatment Landscape Analysis by Major Types
-
9.2 East China Postmenopausal Vaginal Atrophy Treatment Landscape Analysis by Major End-Users
10 Northeast China Postmenopausal Vaginal Atrophy Treatment Landscape Analysis
-
10.1 Northeast China Postmenopausal Vaginal Atrophy Treatment Landscape Analysis by Major Types
-
10.2 Northeast China Postmenopausal Vaginal Atrophy Treatment Landscape Analysis by Major End-Users
11 Southwest China Postmenopausal Vaginal Atrophy Treatment Landscape Analysis
-
11.1 Southwest China Postmenopausal Vaginal Atrophy Treatment Landscape Analysis by Major Types
-
11.2 Southwest China Postmenopausal Vaginal Atrophy Treatment Landscape Analysis by Major End-Users
12 Northwest China Postmenopausal Vaginal Atrophy Treatment Landscape Analysis
-
12.1 Northwest China Postmenopausal Vaginal Atrophy Treatment Landscape Analysis by Major Types
-
12.2 Northwest China Postmenopausal Vaginal Atrophy Treatment Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 Teva Pharmaceutical
-
13.1.1 Teva Pharmaceutical Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 Shionogi
-
13.2.1 Shionogi Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 Novo Nordisk
-
13.3.1 Novo Nordisk Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 Allergan
-
13.4.1 Allergan Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 Pfizer
-
13.5.1 Pfizer Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Postmenopausal Vaginal Atrophy Treatment Market Size and Growth Rate of Creams from 2016 to 2027
-
Figure China Postmenopausal Vaginal Atrophy Treatment Market Size and Growth Rate of Tablets from 2016 to 2027
-
Figure China Postmenopausal Vaginal Atrophy Treatment Market Size and Growth Rate of Patches from 2016 to 2027
-
Figure China Postmenopausal Vaginal Atrophy Treatment Market Size and Growth Rate of Rings from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Postmenopausal Vaginal Atrophy Treatment Market Size and Growth Rate of Topical Estrogen from 2016 to 2027
-
Figure China Postmenopausal Vaginal Atrophy Treatment Market Size and Growth Rate of Systemic Estrogen from 2016 to 2027
-
Figure China Postmenopausal Vaginal Atrophy Treatment Market Size and Growth Rate of Non-hormonal from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Postmenopausal Vaginal Atrophy Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Postmenopausal Vaginal Atrophy Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Postmenopausal Vaginal Atrophy Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Postmenopausal Vaginal Atrophy Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Postmenopausal Vaginal Atrophy Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Postmenopausal Vaginal Atrophy Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Postmenopausal Vaginal Atrophy Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Postmenopausal Vaginal Atrophy Treatment Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Postmenopausal Vaginal Atrophy Treatment
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Postmenopausal Vaginal Atrophy Treatment by Different Types from 2016 to 2027
-
Table Consumption Share of Postmenopausal Vaginal Atrophy Treatment by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Creams
-
Figure Market Size and Growth Rate of Tablets
-
Figure Market Size and Growth Rate of Patches
-
Figure Market Size and Growth Rate of Rings
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Postmenopausal Vaginal Atrophy Treatment by Different End-Users from 2016 to 2027
-
Table Consumption Share of Postmenopausal Vaginal Atrophy Treatment by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Topical Estrogen
-
Figure Market Size and Growth Rate of Systemic Estrogen
-
Figure Market Size and Growth Rate of Non-hormonal
-
Table China Postmenopausal Vaginal Atrophy Treatment Production by Regions
-
Table China Postmenopausal Vaginal Atrophy Treatment Production Share by Regions
-
Figure China Postmenopausal Vaginal Atrophy Treatment Production Share by Regions in 2016
-
Figure China Postmenopausal Vaginal Atrophy Treatment Production Share by Regions in 2021
-
Figure China Postmenopausal Vaginal Atrophy Treatment Production Share by Regions in 2027
-
Table China Postmenopausal Vaginal Atrophy Treatment Consumption by Regions
-
Table China Postmenopausal Vaginal Atrophy Treatment Consumption Share by Regions
-
Figure China Postmenopausal Vaginal Atrophy Treatment Consumption Share by Regions in 2016
-
Figure China Postmenopausal Vaginal Atrophy Treatment Consumption Share by Regions in 2021
-
Figure China Postmenopausal Vaginal Atrophy Treatment Consumption Share by Regions in 2027
-
Table North China Postmenopausal Vaginal Atrophy Treatment Consumption by Types from 2016 to 2027
-
Table North China Postmenopausal Vaginal Atrophy Treatment Consumption Share by Types from 2016 to 2027
-
Figure North China Postmenopausal Vaginal Atrophy Treatment Consumption Share by Types in 2016
-
Figure North China Postmenopausal Vaginal Atrophy Treatment Consumption Share by Types in 2021
-
Figure North China Postmenopausal Vaginal Atrophy Treatment Consumption Share by Types in 2027
-
Table North China Postmenopausal Vaginal Atrophy Treatment Consumption by End-Users from 2016 to 2027
-
Table North China Postmenopausal Vaginal Atrophy Treatment Consumption Share by End-Users from 2016 to 2027
-
Figure North China Postmenopausal Vaginal Atrophy Treatment Consumption Share by End-Users in 2016
-
Figure North China Postmenopausal Vaginal Atrophy Treatment Consumption Share by End-Users in 2021
-
Figure North China Postmenopausal Vaginal Atrophy Treatment Consumption Share by End-Users in 2027
-
Table Central China Postmenopausal Vaginal Atrophy Treatment Consumption by Types from 2016 to 2027
-
Table Central China Postmenopausal Vaginal Atrophy Treatment Consumption Share by Types from 2016 to 2027
-
Figure Central China Postmenopausal Vaginal Atrophy Treatment Consumption Share by Types in 2016
-
Figure Central China Postmenopausal Vaginal Atrophy Treatment Consumption Share by Types in 2021
-
Figure Central China Postmenopausal Vaginal Atrophy Treatment Consumption Share by Types in 2027
-
Table Central China Postmenopausal Vaginal Atrophy Treatment Consumption by End-Users from 2016 to 2027
-
Table Central China Postmenopausal Vaginal Atrophy Treatment Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Postmenopausal Vaginal Atrophy Treatment Consumption Share by End-Users in 2016
-
Figure Central China Postmenopausal Vaginal Atrophy Treatment Consumption Share by End-Users in 2021
-
Figure Central China Postmenopausal Vaginal Atrophy Treatment Consumption Share by End-Users in 2027
-
Table South China Postmenopausal Vaginal Atrophy Treatment Consumption by Types from 2016 to 2027
-
Table South China Postmenopausal Vaginal Atrophy Treatment Consumption Share by Types from 2016 to 2027
-
Figure South China Postmenopausal Vaginal Atrophy Treatment Consumption Share by Types in 2016
-
Figure South China Postmenopausal Vaginal Atrophy Treatment Consumption Share by Types in 2021
-
Figure South China Postmenopausal Vaginal Atrophy Treatment Consumption Share by Types in 2027
-
Table South China Postmenopausal Vaginal Atrophy Treatment Consumption by End-Users from 2016 to 2027
-
Table South China Postmenopausal Vaginal Atrophy Treatment Consumption Share by End-Users from 2016 to 2027
-
Figure South China Postmenopausal Vaginal Atrophy Treatment Consumption Share by End-Users in 2016
-
Figure South China Postmenopausal Vaginal Atrophy Treatment Consumption Share by End-Users in 2021
-
Figure South China Postmenopausal Vaginal Atrophy Treatment Consumption Share by End-Users in 2027
-
Table East China Postmenopausal Vaginal Atrophy Treatment Consumption by Types from 2016 to 2027
-
Table East China Postmenopausal Vaginal Atrophy Treatment Consumption Share by Types from 2016 to 2027
-
Figure East China Postmenopausal Vaginal Atrophy Treatment Consumption Share by Types in 2016
-
Figure East China Postmenopausal Vaginal Atrophy Treatment Consumption Share by Types in 2021
-
Figure East China Postmenopausal Vaginal Atrophy Treatment Consumption Share by Types in 2027
-
Table East China Postmenopausal Vaginal Atrophy Treatment Consumption by End-Users from 2016 to 2027
-
Table East China Postmenopausal Vaginal Atrophy Treatment Consumption Share by End-Users from 2016 to 2027
-
Figure East China Postmenopausal Vaginal Atrophy Treatment Consumption Share by End-Users in 2016
-
Figure East China Postmenopausal Vaginal Atrophy Treatment Consumption Share by End-Users in 2021
-
Figure East China Postmenopausal Vaginal Atrophy Treatment Consumption Share by End-Users in 2027
-
Table Northeast China Postmenopausal Vaginal Atrophy Treatment Consumption by Types from 2016 to 2027
-
Table Northeast China Postmenopausal Vaginal Atrophy Treatment Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Postmenopausal Vaginal Atrophy Treatment Consumption Share by Types in 2016
-
Figure Northeast China Postmenopausal Vaginal Atrophy Treatment Consumption Share by Types in 2021
-
Figure Northeast China Postmenopausal Vaginal Atrophy Treatment Consumption Share by Types in 2027
-
Table Northeast China Postmenopausal Vaginal Atrophy Treatment Consumption by End-Users from 2016 to 2027
-
Table Northeast China Postmenopausal Vaginal Atrophy Treatment Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Postmenopausal Vaginal Atrophy Treatment Consumption Share by End-Users in 2016
-
Figure Northeast China Postmenopausal Vaginal Atrophy Treatment Consumption Share by End-Users in 2021
-
Figure Northeast China Postmenopausal Vaginal Atrophy Treatment Consumption Share by End-Users in 2027
-
Table Southwest China Postmenopausal Vaginal Atrophy Treatment Consumption by Types from 2016 to 2027
-
Table Southwest China Postmenopausal Vaginal Atrophy Treatment Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Postmenopausal Vaginal Atrophy Treatment Consumption Share by Types in 2016
-
Figure Southwest China Postmenopausal Vaginal Atrophy Treatment Consumption Share by Types in 2021
-
Figure Southwest China Postmenopausal Vaginal Atrophy Treatment Consumption Share by Types in 2027
-
Table Southwest China Postmenopausal Vaginal Atrophy Treatment Consumption by End-Users from 2016 to 2027
-
Table Southwest China Postmenopausal Vaginal Atrophy Treatment Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Postmenopausal Vaginal Atrophy Treatment Consumption Share by End-Users in 2016
-
Figure Southwest China Postmenopausal Vaginal Atrophy Treatment Consumption Share by End-Users in 2021
-
Figure Southwest China Postmenopausal Vaginal Atrophy Treatment Consumption Share by End-Users in 2027
-
Table Northwest China Postmenopausal Vaginal Atrophy Treatment Consumption by Types from 2016 to 2027
-
Table Northwest China Postmenopausal Vaginal Atrophy Treatment Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Postmenopausal Vaginal Atrophy Treatment Consumption Share by Types in 2016
-
Figure Northwest China Postmenopausal Vaginal Atrophy Treatment Consumption Share by Types in 2021
-
Figure Northwest China Postmenopausal Vaginal Atrophy Treatment Consumption Share by Types in 2027
-
Table Northwest China Postmenopausal Vaginal Atrophy Treatment Consumption by End-Users from 2016 to 2027
-
Table Northwest China Postmenopausal Vaginal Atrophy Treatment Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Postmenopausal Vaginal Atrophy Treatment Consumption Share by End-Users in 2016
-
Figure Northwest China Postmenopausal Vaginal Atrophy Treatment Consumption Share by End-Users in 2021
-
Figure Northwest China Postmenopausal Vaginal Atrophy Treatment Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Teva Pharmaceutical
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva Pharmaceutical
-
Figure Sales and Growth Rate Analysis of Teva Pharmaceutical
-
Figure Revenue and Market Share Analysis of Teva Pharmaceutical
-
Table Product and Service Introduction of Teva Pharmaceutical
-
Table Company Profile and Development Status of Shionogi
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shionogi
-
Figure Sales and Growth Rate Analysis of Shionogi
-
Figure Revenue and Market Share Analysis of Shionogi
-
Table Product and Service Introduction of Shionogi
-
Table Company Profile and Development Status of Novo Nordisk
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novo Nordisk
-
Figure Sales and Growth Rate Analysis of Novo Nordisk
-
Figure Revenue and Market Share Analysis of Novo Nordisk
-
Table Product and Service Introduction of Novo Nordisk
-
Table Company Profile and Development Status of Allergan
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Allergan
-
Figure Sales and Growth Rate Analysis of Allergan
-
Figure Revenue and Market Share Analysis of Allergan
-
Table Product and Service Introduction of Allergan
-
Table Company Profile and Development Status of Pfizer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer
-
Figure Sales and Growth Rate Analysis of Pfizer
-
Figure Revenue and Market Share Analysis of Pfizer
-
Table Product and Service Introduction of Pfizer
-
